1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

TOMA Biosciences, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2011

Location

Holland MI US

Primary Industry

Biotechnology

About

Founded in 2011 and based in California, US, TOMA Biosciences, Inc. develops the SIGNOME™ Tumor Profiling System, a diagnostic technology composed of reagents and analytics to perform gene sequencing, genetic variance detection of tumor samples, identify treatments, and provide clinical reports.
Current Investors
Paladin Capital Group, Prolog Ventures, Correlation Ventures

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare IT, Oncology/Cancer Treatment
Website
www.tomabio.com
Verticals
Cloud Computing, HealthTech
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo